Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 5
1965 67
1966 120
1967 121
1968 162
1969 224
1970 213
1971 272
1972 297
1973 364
1974 353
1975 456
1976 466
1977 505
1978 584
1979 573
1980 548
1981 639
1982 673
1983 777
1984 788
1985 842
1986 930
1987 927
1988 929
1989 967
1990 1104
1991 1076
1992 983
1993 1003
1994 1278
1995 1372
1996 1259
1997 1269
1998 1288
1999 1319
2000 1331
2001 1244
2002 1251
2003 1364
2004 1424
2005 1601
2006 1641
2007 1819
2008 1738
2009 1607
2010 1650
2011 1931
2012 2021
2013 2139
2014 2107
2015 1904
2016 1742
2017 1630
2018 1517
2019 1425
2020 1361
2021 1321
2022 518
Text availability
Article attribute
Article type
Publication date

Search Results

56,435 results
Results by year
Filters applied: . Clear all
Page 1
Gabapentin treatment for alcohol dependence: a randomized clinical trial.
Mason BJ, Quello S, Goodell V, Shadan F, Kyle M, Begovic A. Mason BJ, et al. JAMA Intern Med. 2014 Jan;174(1):70-7. doi: 10.1001/jamainternmed.2013.11950. JAMA Intern Med. 2014. PMID: 24190578 Free PMC article. Clinical Trial.
IMPORTANCE: Approved medications for alcohol dependence are prescribed for less than 9% of US alcoholics. ...Increased implementation of pharmacological treatment of alcohol dependence in primary care may be a major benefit of gabapentin as a treatment option …
IMPORTANCE: Approved medications for alcohol dependence are prescribed for less than 9% of US alcoholics. ...Increased impleme …
Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial.
Saitz R, Mayo-Smith MF, Roberts MS, Redmond HA, Bernard DR, Calkins DR. Saitz R, et al. JAMA. 1994 Aug 17;272(7):519-23. JAMA. 1994. PMID: 8046805 Clinical Trial.
OBJECTIVE: To assess the effect of an individualized treatment regimen on the intensity and duration of medication treatment for alcohol withdrawal. DESIGN: A randomized double-blind, controlled trial. ...PATIENTS: One hundred one patients admitted for the treatment of …
OBJECTIVE: To assess the effect of an individualized treatment regimen on the intensity and duration of medication treatment for alcohol
Double-Blind Randomized Clinical Trial of Prazosin for Alcohol Use Disorder.
Simpson TL, Saxon AJ, Stappenbeck C, Malte CA, Lyons R, Tell D, Millard SP, Raskind M. Simpson TL, et al. Am J Psychiatry. 2018 Dec 1;175(12):1216-1224. doi: 10.1176/appi.ajp.2018.17080913. Epub 2018 Aug 29. Am J Psychiatry. 2018. PMID: 30153753 Free PMC article. Clinical Trial.
OBJECTIVE: Current medications for alcohol use disorder do not target brain noradrenergic pathways. Theoretical and preclinical evidence suggests that noradrenergic circuits may be involved in alcohol reinforcement and relapse. After a positive pilot study, the auth …
OBJECTIVE: Current medications for alcohol use disorder do not target brain noradrenergic pathways. Theoretical and preclinical evide …
Exploring the Role of Alcohol Metabolizing Genotypes in a 12-Week Clinical Trial of Naltrexone for Alcohol Use Disorder.
Castaldelli-Maia JM, Malbergier A, de Oliveira ABP, Amaral RA, Negrão AB, Gonçalves PD, Ventriglio A, de Berardis D, de Antonio J, Firigato I, Gattás GJF, de Toledo Gonçalves F. Castaldelli-Maia JM, et al. Biomolecules. 2021 Oct 10;11(10):1495. doi: 10.3390/biom11101495. Biomolecules. 2021. PMID: 34680127 Free PMC article. Clinical Trial.
The outcome of alcohol use has been monitored employing the timeline follow-back during the treatment. ...Further studies should be performed to investigate the relationship between alcohol metabolizing genotypes, the family history of alcohol use disorders a …
The outcome of alcohol use has been monitored employing the timeline follow-back during the treatment. ...Further studies should be p …
Changing Alcohol Cravings Using Social Media Comments.
Noel JK, Lakhan HA. Noel JK, et al. Subst Use Misuse. 2021;56(3):377-387. doi: 10.1080/10826084.2020.1868518. Epub 2021 Jan 10. Subst Use Misuse. 2021. PMID: 33427009 Clinical Trial.
Alcohol cravings, measured using the Desires for Alcohol Questionnaire (DAQ), were assessed before and after ad exposure. ...Conclusions: The findings suggest that user-generated comments can influence the desire to drink and smoking urges, beyond the effects of ads
Alcohol cravings, measured using the Desires for Alcohol Questionnaire (DAQ), were assessed before and after ad exposure. ...C
Pilot investigation: randomized-controlled analog trial for alcohol and tobacco smoking co-addiction using contingency management.
Orr MF, Lederhos Smith C, Finlay M, Martin SC, Brooks O, Oluwoye OA, Leickly E, McDonell M, Burduli E, Barbosa-Leiker C, Layton M, Roll JM, McPherson SM. Orr MF, et al. Behav Pharmacol. 2018 Aug;29(5):462-468. doi: 10.1097/FBP.0000000000000379. Behav Pharmacol. 2018. PMID: 29561290 Free PMC article. Clinical Trial.
We used a 2 [CM vs. noncontingent control (NC) for alcohol]2 (CM vs. NC for smoking tobacco) factorial design, with alcohol intake (through urinary ethyl glucuronide) and tobacco smoking (through urinary cotinine) as the primary outcomes. ...Similarly, compared with …
We used a 2 [CM vs. noncontingent control (NC) for alcohol]2 (CM vs. NC for smoking tobacco) factorial design, with alcohol in …
Filling the gap between lab and clinical impact: An open randomized diagnostic trial comparing urinary ethylglucuronide and ethanol in alcohol dependent outpatients.
Barrio P, Teixidor L, Ortega L, Lligoña A, Rico N, Bedini JL, Vieta E, Gual A. Barrio P, et al. Drug Alcohol Depend. 2018 Feb 1;183:225-230. doi: 10.1016/j.drugalcdep.2017.11.015. Epub 2017 Dec 27. Drug Alcohol Depend. 2018. PMID: 29291550 Clinical Trial.
The aim of this study was to assess, in a randomized design, the implications of EtG screening on alcohol outcomes, compared to screening with a low sensitivity biomarker such as ethanol. METHODS: Alcohol dependent outpatients were randomized to either 24 wee …
The aim of this study was to assess, in a randomized design, the implications of EtG screening on alcohol outcomes, compared to scree …
Acute alcohol effects on impulsive choice in adolescents.
Bernhardt N, Obst E, Nebe S, Pooseh S, Wurst FM, Weinmann W, Smolka MN, Zimmermann US. Bernhardt N, et al. J Psychopharmacol. 2019 Mar;33(3):316-325. doi: 10.1177/0269881118822063. Epub 2019 Jan 24. J Psychopharmacol. 2019. PMID: 30676200 Clinical Trial.
Further, higher risk aversion for probabilistic gains and higher loss aversion during alcohol condition were related to higher levels of real-life alcohol consumption and a family history of alcohol problems, respectively. ...It rather appears that alcohol
Further, higher risk aversion for probabilistic gains and higher loss aversion during alcohol condition were related to higher levels …
Naltrexone and alcohol effects on craving for cigarettes in heavy drinking smokers.
Green R, Bujarski S, Lim AC, Venegas A, Ray LA. Green R, et al. Exp Clin Psychopharmacol. 2019 Jun;27(3):257-264. doi: 10.1037/pha0000252. Epub 2019 Jan 10. Exp Clin Psychopharmacol. 2019. PMID: 30628813 Free PMC article. Clinical Trial.
Self-reported subjective craving for cigarettes and for alcohol was recorded during each experimental session. Craving for cigarettes and alcohol increased significantly throughout the intravenous alcohol administration. ...Naltrexone significantly reduced cr …
Self-reported subjective craving for cigarettes and for alcohol was recorded during each experimental session. Craving for cigarettes …
A randomized clinical trial of a targeted intervention to moderate alcohol use and alcohol-related problems in at-risk adolescents.
Thush C, Wiers RW, Theunissen N, Van den Bosch J, Opdenacker J, van Empelen P, Moerbeek M, Feron FJ. Thush C, et al. Pharmacol Biochem Behav. 2007 Feb;86(2):368-76. doi: 10.1016/j.pbb.2006.07.023. Epub 2006 Aug 22. Pharmacol Biochem Behav. 2007. PMID: 16928395 Clinical Trial.
Additionally, this intervention contained the new element of discussing biological, cognitive and social risk factors for developing alcohol problems. We investigated whether this seven session program was successful in changing cognitive determinants of drinking behavior …
Additionally, this intervention contained the new element of discussing biological, cognitive and social risk factors for developing alco
56,435 results
You have reached the last available page of results. Please see the User Guide for more information.